The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment

To help provide relief without the risk of abuse and overdoses, one pharmaceutical company is revealing its new pill designed to not trigger those dangers.

I’m Conway Gittens reporting from the New York Stock Exchange. Here’s what we’re watching on TheStreet today. Wall Street heads into the weekend with modest strength - and that’s no small feat given how the week began.